BORA LIM

TitleAssistant Professor
InstitutionMD Anderson
DepartmentBreast Medical Oncology
Address1155 Pressler St
Houston TX 77030-3721
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Lim B, Greer Y, Lipkowitz S, Takebe N. Novel Apoptosis-Inducing Agents for the Treatment of Cancer, a New Arsenal in the Toolbox. Cancers (Basel). 2019 Jul 31; 11(8). PMID: 31370269.
      Citations:    
    2. Lim B, Woodward WA, Wang X, Reuben JM, Ueno NT. Author Correction: Inflammatory breast cancer biology: the tumour microenvironment is key. Nat Rev Cancer. 2018 Aug; 18(8):526. PMID: 29748602.
      Citations: 2     Fields:    
    3. Lim B, Woodward WA, Wang X, Reuben JM, Ueno NT. Inflammatory breast cancer biology: the tumour microenvironment is key. Nat Rev Cancer. 2018 08; 18(8):485-499. PMID: 29703913.
      Citations: 28     Fields:    Translation:HumansCells
    4. Is the future of personalized therapy in triple-negative breast cancer based on molecular subtype?. Oncotarget. 6:12890-12908.
    5. A multiplexed marker-based algorithm for diagnosis of carcinoma of unknown primary using circulating tumor cells. Oncotarget. 7:3662-3676.
    6. A combinatory strategy for detection of live CTCs using microfiltration and a new telomerase-selective adenovirus. Molecular Cancer Therapeutics. 14:835-843.
    7. Stroke syndrome secondary to hypercoagulability of lung cancer. Community Oncology. 5:595-596.
    8. Current treatment of early breast cancer. F1000Research. 3.
    9. Comprehensive Two- and Three-Dimensional RNAi Screening Identifies PI3K Inhibition as a Complement to MEK Inhibitor AS703026 for Combination Treatment of Triple-Negative Breast Cancer. Journal of Cancer. 6:1306-1319.
    10. A combinatory strategy for detection of live CTCs using microfiltration and a new telomerase-selective adenovirus. BMJ Open. 5.
    11. Molecular profiling of 6,892 colorectal cancer samples suggests different possible treatment options specific to metastatic sites. Cancer Biology and Therapy. 16:1726-1737.
    LIM's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (22)
    Explore
    _
    Co-Authors (3)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _